Award Number: DAMD17-02-1-0261 TITLE: Nuclear Imaging for Assessment of Prostate Cancer Gene Therapy
نویسنده
چکیده
PSA promoter has been demonstrated the utility for tissue-specific toxic gene therapy in prostate cancer models. Characterization of foreign gene overexpression in normal animals elicited by PSA promoter should help evaluate therapy safety. Here we constructed an adenovirus vector (AdPSA-Luc), containing firefly luciferase gene under the control of the 5837 bp long prostate-specific antigen promoter. A charge coupled device video camera was used to non-invasively image expression of firefly luciferase in nude mice on days 3, 7, 11 after injection of 2 · 10 PFU of AdPSA-Luc virus via tail vein. The result showed highly specific expression of the luciferase gene in lungs of mice from day 7. The finding indicates the potential limitations of the suicide gene therapy of prostate cancer based on selectivity of PSA promoter. By contrary, it has encouraging implications for further development of vectors via PSA promoter to enable gene therapy for pulmonary diseases. 2005 Elsevier Inc. All rights reserved.
منابع مشابه
Imaging Cellular Proliferation in Prostate Cancer with Positron Emission Tomography
Prostate cancer remains a major public health problem worldwide. Imaging plays an important role in the assessment of disease at all its clinical phases, including staging, restaging after definitive therapy, evaluation of therapy response, and prognostication. Positron emission tomography with a number of biologically targeted radiotracers has been demonstrated to have potential diagnostic and...
متن کاملAD AWARD NUMBER DAMD17-97-1-7144 TITLE: Tomosynthesis Breast Imaging: Early Detection and Characterization of Breast Cancer PRINCIPAL INVESTIGATOR:
AWARD NUMBER DAMD17-97-1-7144 TITLE: Tomosynthesis Breast Imaging: Early Detection and Characterization of Breast Cancer PRINCIPAL INVESTIGATOR: Loren T. Niklason, Ph.D. CONTRACTING ORGANIZATION: Massachusetts General Hospital Boston, Massachusetts 02114 REPORT DATE: July 1998 ^\$> TYPE OF REPORT: Annual "P^ PREPARED FOR: Commander U.S. Army Medical Research and Materiel Command Fort Detrick, M...
متن کاملAWARD NUMBER: DAMD17-02-1-0503 TITLE: ATM Mutations and the Development of Severe Radiation-Induced Morbidity Following Radiotherapy for Breast Cancer PRINCIPAL INVESTIGATOR:
متن کامل
AWARD NUMBER: DAMD17-02-1-0350 TITLE: “Identification of the Downstream Promoter Targets of Smad Tumor Suppressors in Human Breast Cancer Cells” PRINCIPAL INVESTIGATOR:
متن کامل
AD AWARD NUMBER DAMD17-96-1-6079 TITLE: Breast Cancer Genes Identified by Loss of Heterozygosity PRINCIPAL INVESTIGATOR:
AWARD NUMBER DAMD17-96-1-6079 TITLE: Breast Cancer Genes Identified by Loss of Heterozygosity PRINCIPAL INVESTIGATOR: Roy J. Riblet, Ph.D. CONTRACTING ORGANIZATION: Medical Biology Institute La Jolla, California 92037 REPORT DATE: May 1998 TYPE OF REPORT: Final PREPARED FOR: Commander U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012 DISTRIBUTION STATEMENT: Appro...
متن کامل